David James Lennon - Apr 1, 2025 Form 4 Insider Report for Whitehawk Therapeutics, Inc. (WHWK)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
Stock symbol
WHWK
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/3/2025, 07:22 PM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WHWK Stock Option (right to buy) Award $0 +776K $0.00 776K Apr 1, 2025 Common Stock 776K $1.70 Direct F1
transaction WHWK Restricted Stock Units Award $0 +776K $0.00 776K Apr 1, 2025 Common Stock 776K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F3 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.